Lixte Biotechnology Holdings, Inc. (LIXT) DCF Valuation

Lixte Biotechnology Holdings, Inc. (LIXT) DCF Valuation

US | Healthcare | Biotechnology | NASDAQ
Lixte Biotechnology Holdings, Inc. (LIXT) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Lixte Biotechnology Holdings, Inc. (LIXT) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Evaluate Lixte Biotechnology Holdings, Inc.'s financial outlook like an expert! This (LIXT) DCF Calculator comes with pre-filled financial data and offers full flexibility to modify revenue growth, WACC, margins, and other critical assumptions to align with your projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -2.5 .0 .0 .0 .0 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation 2.5 3.3 6.7 6.3 5.1 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -5.0 -3.3 -6.7 -6.3 -5.1 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 2.6 5.1 4.8 5.4 4.2 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .1 .2 .2 .2 .1 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -4.9 -3.3 -6.7 -6.3 -5.1 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -2.3 .1 .0 .0 -.1 -.1 .0 .0 .0 .0
WACC, % 5.39 5.39 5.39 5.39 5.39 5.39 5.39 5.39 5.39 5.39
PV UFCF
SUM PV UFCF -.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 0
Net Debt -4
Equity Value 4
Diluted Shares Outstanding, MM 2
Equity Value Per Share 2.13

What You Will Receive

  • Customizable Excel Template: A fully editable Excel-based DCF Calculator featuring pre-populated financial data for Lixte Biotechnology Holdings, Inc. (LIXT).
  • Accurate Market Data: Access to historical performance and projected estimates (highlighted in the yellow cells).
  • Adjustable Forecasts: Modify key assumptions such as revenue growth, EBITDA margin, and WACC.
  • Instant Calculations: Quickly visualize how your inputs affect Lixte's valuation.
  • Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
  • Intuitive Layout: Organized for straightforward navigation and includes step-by-step guidance.

Key Features

  • Comprehensive LIXT Data: Pre-filled with Lixte Biotechnology's historical performance metrics and future growth projections.
  • Customizable Parameters: Modify variables such as revenue growth, profit margins, discount rates, tax obligations, and capital investments.
  • Interactive Valuation Model: Instant updates to Net Present Value (NPV) and intrinsic value based on your customized inputs.
  • Scenario Analysis: Develop various forecasting scenarios to evaluate different valuation possibilities.
  • Intuitive Interface: Designed to be straightforward and accessible for both experienced professionals and newcomers.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based LIXT DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
  3. Instant Calculations: The model automatically recalculates Lixte’s intrinsic value.
  4. Test Scenarios: Experiment with different assumptions to assess potential valuation impacts.
  5. Analyze and Decide: Utilize the findings to inform your investment or financial evaluations.

Why Choose This Calculator for Lixte Biotechnology Holdings, Inc. (LIXT)?

  • Accurate Data: Up-to-date Lixte financials provide dependable valuation outcomes.
  • Customizable: Tailor essential parameters such as growth rates, WACC, and tax rates to fit your forecasts.
  • Time-Saving: Built-in calculations save you the effort of starting from scratch.
  • Professional-Grade Tool: Crafted for investors, analysts, and consultants in the biotech sector.
  • User-Friendly: Simple design and clear instructions make it accessible for all users.

Who Should Use This Product?

  • Investors: Evaluate Lixte Biotechnology's valuation before making stock transactions.
  • CFOs and Financial Analysts: Optimize valuation methodologies and assess financial forecasts.
  • Startup Founders: Gain insights into how biotechnology firms like Lixte are appraised.
  • Consultants: Provide comprehensive valuation analyses for client projects.
  • Students and Educators: Utilize current data to practice and instruct on valuation strategies.

What the Template Contains

  • Historical Data: Includes Lixte Biotechnology Holdings, Inc.'s (LIXT) past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate Lixte Biotechnology Holdings, Inc.'s (LIXT) intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of Lixte Biotechnology Holdings, Inc.'s (LIXT) financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.